BDNF and Huntington disease: By analyzing 12 CpG dinucleotides at promoter IV of BDNF in whole blood samples using bisulfite sequencing they found that four CpG sites were differentially methylated between HD and control samples, three having increased while one having decreased methylation in HD patients.